These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22682987)

  • 1. Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia.
    Wang J; Fan X; Liu D; Yi Z; Freudenreich O; Goff D; Henderson DC
    Schizophr Res; 2012 Sep; 140(1-3):260-1. PubMed ID: 22682987
    [No Abstract]   [Full Text] [Related]  

  • 2. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia.
    Vancampfort D; Knapen J; Probst M; van Winkel R; Deckx S; Maurissen K; Peuskens J; De Hert M
    Psychiatry Res; 2010 May; 177(3):271-9. PubMed ID: 20406713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia.
    Vancampfort D; Probst M; Knapen J; Carraro A; De Hert M
    Psychiatry Res; 2012 Dec; 200(2-3):73-8. PubMed ID: 22497956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring?
    Guillemot J; Laborie C; Dutriez-Casteloot I; Maron M; Deloof S; Lesage J; Breton C; Vieau D
    Eur J Pharmacol; 2011 Sep; 667(1-3):13-6. PubMed ID: 21664905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole in schizophrenia: consensus guidelines.
    Travis MJ; Burns T; Dursun S; Fahy T; Frangou S; Gray R; Haddad PM; Hunter R; Taylor DM; Young AH
    Int J Clin Pract; 2005 Apr; 59(4):485-95. PubMed ID: 15853869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of adipokines with metabolic disorders in patients with schizophrenia: Results of comparative study with mental healthy cohort.
    Tanyanskiy DA; Martynikhin IA; Rotar OP; Konradi AO; Sokolian NA; Neznanov NG; Denisenko AD
    Diabetes Metab Syndr; 2015; 9(3):163-7. PubMed ID: 25952038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between metabolic syndrome and cognition in patients with schizophrenia.
    Lindenmayer JP; Khan A; Kaushik S; Thanju A; Praveen R; Hoffman L; Cherath L; Valdez G; Wance D
    Schizophr Res; 2012 Dec; 142(1-3):171-6. PubMed ID: 23106932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia.
    Yang L; Chen J; Liu D; Yu S; Cong E; Li Y; Wu H; Yue Y; Zuo S; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():136-41. PubMed ID: 25201120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome.
    Shi L; Zhao Y; Fonseca V; Ascher-Svanum H; Chiang YJ; Winstead D
    Curr Med Res Opin; 2010 Oct; 26(10):2499-506. PubMed ID: 20828361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters.
    Hahn MK; Cohn T; Teo C; Remington G
    Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):186-96. PubMed ID: 23302448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
    Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
    Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of metabolic parameters during electroconvulsive treatment of schizophrenia: Preliminary results.
    Wysokiński A
    Psychiatry Clin Neurosci; 2015 May; 69(5):305. PubMed ID: 25041371
    [No Abstract]   [Full Text] [Related]  

  • 14. Follow-up interventions in persons with schizophrenia and metabolic syndrome.
    Kølbæk P; Schiöth E; Aagaard J; Munk-Jørgensen P
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1059-60. PubMed ID: 25277542
    [No Abstract]   [Full Text] [Related]  

  • 15. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
    Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
    Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic treatment and negative symptoms in deficit and nondeficit schizophrenia.
    Bustillo JR; Kirkpatrick B; Buchanan RW
    Biol Psychiatry; 1995 Jul; 38(1):64-7. PubMed ID: 7548474
    [No Abstract]   [Full Text] [Related]  

  • 17. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggression and schizophrenia: efficacy of risperidone.
    Buckley PF; Ibrahim ZY; Singer B; Orr B; Donenwirth K; Brar PS
    J Am Acad Psychiatry Law; 1997; 25(2):173-81. PubMed ID: 9213289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.
    De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics.
    Vuksan-Ćusa B; Jakovljević M; Sagud M; Mihaljević Peleš A; Marčinko D; Topić R; Mihaljević S; Sertić J
    Psychiatry Res; 2011 Aug; 189(1):21-5. PubMed ID: 21216014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.